ArticleJournal of pharmacy & bioallied sciences2025
Salivary Zinc Levels in Rheumatoid Arthritis.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to evaluate and compare salivary zinc levels in individuals diagnosed with rheumatoid arthritis and healthy controls. Materials and Methods: A total of 20 participants were included in the study after obtaining informed consent. The participants were divided into two equal groups. Group 1 consisted of 10 healthy individuals who served as controls, while Group 2 included 10 individuals diagnosed with rheumatoid arthritis. Saliva samples were collected from all participants, and the zinc levels were measured and analyzed to determine any differences between the two groups. Results: The average salivary zinc level in the rheumatoid arthritis group (Group 2) was 83.52 ± 5.9 μg/dL. In comparison, the control group (Group 1) showed a lower mean level of 69.56 ± 11.2 μg/dL. This indicates a noticeable difference in zinc concentrations between the two groups. Conclusion: Based on the findings, individuals with rheumatoid arthritis exhibited higher salivary zinc levels compared to healthy controls. This suggests that salivary zinc concentration may be altered in patients with rheumatoid arthritis and could potentially serve as a marker for disease activity or metabolic changes associated with the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.